Physician profile
Thomas Salazer
NPI 1205803152
$1,373.09
in general payments reported to CMS, 2019-2025
8 companies · $306 in 2025
The $306 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.77 · 2021: $228 · 2022: $219 · 2023: $265 · 2024: $339 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $909.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nxstage Medical, INC. | $528.20 | 2019-2025 | Nxstage System One |
| Potrero Medical, INC. | $154.35 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $150.00 | 2023 | |
| Amgen INC. | $149.77 | 2021-2024 | Tavneos |
| Novartis Pharmaceuticals Corporation | $128.46 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $124.98 | 2021 | |
| Glaxosmithkline, LLC. | $120.65 | 2022 | |
| Fresenius USA Marketing, INC. | $16.68 | 2023 | Velphoro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Salazer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.